Tatva Chintan Pharma Chem Limited(IN:TATVA)
₹1,685.35+24.95 (+1.50%)
IN:TATVA
Tatva Chintan Pharma Chem Limited financials statements
₹1,685.35
At close:+24.95 (+1.50%)
Want to see IN:TATVA full AI Analyst Report?
Tatva Chintan Pharma Chem Limited (TATVA) Income Statement
3 Followers
Tatva Chintan Pharma Chem Limited Income Statement
Last quarter (Q2 2027), Tatva Chintan Pharma Chem Limited's total revenue was ₹2.17B, an increase of 75.94% from the same quarter last year. In Q2, Tatva Chintan Pharma Chem Limited's net income was ₹214.51M. See Tatva Chintan Pharma Chem Limited’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| ₹ 5.06B | ₹ 3.83B | ₹ 3.43B | ₹ 4.24B | ₹ 4.34B | |
| ₹ 1.82B | ₹ 619.74M | ₹ 1.60B | ₹ 1.91B | ₹ 2.32B | |
| ₹ 1.25B | ₹ 529.16M | ₹ 138.32M | ₹ 491.26M | ₹ 356.65M | |
| Depreciation and Amortization | ₹ 368.47M | ₹ 276.59M | ₹ 256.05M | ₹ 95.55M | ₹ 81.80M |
| ₹ 967.07M | ₹ -875.86M | ₹ 693.88M | ₹ 680.24M | ₹ 1.09B | |
| ₹ 563.11M | ₹ 90.58M | ₹ 1.46B | ₹ 1.42B | ₹ 1.96B | |
| ₹ 6.98M | ₹ -14.79M | ₹ -1.03B | ₹ -972.59M | ₹ -923.59M | |
| ₹ 570.09M | ₹ 75.79M | ₹ 435.68M | ₹ 445.65M | ₹ 1.04B | |
| ₹ 420.54M | ₹ 57.13M | ₹ 303.54M | ₹ 454.87M | ₹ 958.74M | |
| Per Share Metrics | |||||
| Basic EPS | ₹ 17.98 | ₹ 2.44 | ₹ 13.26 | ₹ 20.52 | ₹ 44.59 |
| Diluted EPS | ₹ 17.98 | ₹ 2.44 | ₹ 13.26 | ₹ 20.52 | ₹ 44.59 |
| Weighted Average Shares Outstanding | 23.39M | 23.41M | 22.89M | 22.17M | 21.50M |
| Weighted Average Shares Outstanding (Diluted) | 23.39M | 23.41M | 22.89M | 22.17M | 21.50M |
Currency in INR

